Client
- Name
- GENENTECH INC
- Location
- District of Columbia · United States of America
Registrant
- Firm
- GENENTECH, INC
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
10 issuesImmigration
-Issues relating to limits and restrictions on the immigration of high skilled workers -Issues relating to the immigration of medical researchers
LobbyistsMATTHEW L SULKALA · THOMAS L. STOLL · mr DAVID B BURT
TargetedLabor, Dept of (DOL) · Homeland Security, Dept of (DHS)
Budget/Appropriations
Bills -H.R. 2617 Consolidated Appropriations Act, FY2023 Issues -Issues related to FDA and HHS program funding for the FY23 Labor, HHS, Education and Related Agencies, and FY22 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills -Strategic National Stockpile (SNS) Funding and Oversight -Funding for FDA e-labeling rule implementation -Patient access to Part B medicines during the COVID-19 public health emergency -Issues related to 340B program oversight -Support for increased investments to address antimicrobial resistance -Deficit reduction, reconciliation
LobbyistsMATTHEW L SULKALA · ELISE MARIE CONNER · CATHERINE LYTTON PHILLIPS · RAVI UPADHYAY · JILL SHOTZBERGER · THOMAS L. STOLL · mr DAVID B BURT · CALEB GRAFF · mr DAVID COOLING · mrs VANESSA GANNON BURT
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Bills -S. 4417 Patent Trial and Appeal Board Reform Act -S. 4734 Patent Eligibility Restoration Act -S. 1435 - Affordable Prescriptions for Patients Act of 2021 -H.R. 2873 Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 -H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act Issues -Intellectual property and process patent issues -Patent litigation reforms -PTAB and IPR processes -Section 101 Reform -Domestic and international compulsory licensing issues -March-in Rights